Results 181 to 190 of about 53,280 (246)

Clinical efficacy of tofacitinib in active ankylosing spondylitis and dynamic changes in gut microbiota: an exploratory descriptive four-case series with 16S rRNA sequencing analysis. [PDF]

Front Immunol
Wang L, Xie W, Li J, Chen J, Huang Y.
europepmc   +1 more source

Kinase inhibitors in clinical practice: An expanding world [PDF]

, 2017
Kapur, Reuben, Pandey, Ruchi
core   +1 more source

Lessons from extended induction and practical evidence for improving tofacitinib therapy in ulcerative colitis. [PDF]

World J Gastroenterol
Fouad Y, Aboelela AS.
europepmc   +1 more source

Tofacitinib in rheumatoid arthritis: a German real-world study with focus on treatment changes, effectiveness and patient-reported outcomes (ESCALATE-RA). [PDF]

BMJ Open
Krueger K, Behrens F, Brandt-Juergens J, Detert J, Feuchtenberger M, Prothmann U, Behmer O, Hsieh MM, Jobst J, Klaus P, Meng T.   +10 more
europepmc   +1 more source

Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review. [PDF]

Front Immunol
Wan Z, Wang Y, Yang D.
europepmc   +1 more source

Multimodal Approach for Recalcitrant Melasma Using Picosecond Laser and Topical JAK Inhibition: A Case Report. [PDF]

J Cosmet Dermatol
Ashkanani H, AlZaabi M, AlRasheed A, AlDaraji W.   +3 more
europepmc   +1 more source

JAK inhibitor tofacitinib alleviates secretory dysfunction and Th17/Treg imbalance in a Sjögren's disease murine model. [PDF]

Ann Med
Lin Y, Ou Y, Su J, Xu J, Liu C, He K, Zhou L, Wu D, Chen J.   +8 more
europepmc   +1 more source

FDA-approved small-molecule kinase inhibitors [PDF]

, 2015
Clausen, Mads Hartvig, Nielsen, Thomas E., Wu, Peng   +2 more
core   +1 more source

Authors' Response to Comment on published article "A Real-World Study of Tofacitinib in Indian Patients with Refractory Moderate-to-Severe Atopic Dermatitis, its Economic Considerations and Immunological Rationale". [PDF]

Indian Dermatol Online J
Sardana K, Sharath S, Meena SK, Khurana A, Dhir B.   +4 more
europepmc   +1 more source

Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort

International Journal of Dermatology, Volume 65, Issue 5, Page 1040-1043, May 2026.
Alonso García‐Núñez, Antonio Alcalá Ramírez Del Puerto, Roberto Daza‐García, María Teresa Monserrat‐García, Mercedes Morillo‐Andújar, Javier Jesús Domínguez‐Cruz, Román Barabash‐Neila   +6 more
wiley   +1 more source